NEW YORK (GenomeWeb) - Luminex reported after the close of the market Monday a 6 percent rise in its second quarter revenues, driven by a 22 percent jump in assay revenues.

For the three-month period ended June 30, Luminex's revenues rose to $58.9 million from $55.6 million in the same period a year earlier, topping the consensus Wall Street estimate of $57 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.